Showing results (21-30 of 76) with videos related to
Sort By:
Pageof 8
Journal of Clinical Pharmacology|October 28, 2011
Food increased the bioavailability of BMS-690514, an orally active EGFR/HER2/VEGF receptor kinase inhibitor, in healthy subjectsBlisse Vakkalagadda, Jong-Soon Park, Christoph M Ahlers, et al.BMC Pharmacology & Toxicology|February 6, 2024
Large variation in anti-factor Xa levels with nadroparin as thromboprophylaxis in COVID-19 and non-COVID-19 critically ill patientsMonique M R de Maat, Henk J van Leeuwen, Lian Roovers, et al.Journal of Pathology Informatics|September 25, 2014
Can digital pathology result in cost savings? A financial projection for digital pathology implementation at a large integrated health care organizationJonhan Ho, Stefan M Ahlers, Curtis Stratman, et al.Molecular and Cellular Endocrinology|February 25, 2000
Mouse growth hormone transcription factor Zn-16: unique bipartite structure containing tandemly repeated zinc finger domains not reported in rat Zn-15T C VanderHeyden, P W Wojtkiewicz, T C Voss, et al.Journal of Clinical Pharmacology|February 26, 2013
Inhibitory effect of ketoconazole on the pharmacokinetics of a multireceptor tyrosine kinase inhibitor BMS-690514 in healthy participants: assessing the mechanism of the interaction with physiologically-based pharmacokinetic simulationsZheng Yang, Blisse Vakkalagadda, Guoxiang Shen, et al.Journal of Acquired Immune Deficiency Syndromes|January 1, 1992
Cytokine dysregulation in AIDS: in vivo overexpression of mRNA of tumor necrosis factor-alpha and its correlation with that of the inflammatory cytokine GROB J Dezube, A B Pardee, L A Beckett, et al.Intervirology|January 24, 2006
A new HBsAg screening assay designed for sensitive detection of HBsAg subtypes and variantsM H van Roosmalen, J J de Jong, W Haenen, et al.Cancer Chemotherapy and Pharmacology|March 26, 2014
A phase I study of oral ixabepilone in patients with advanced solid tumorsJohn F Deeken, John L Marshall, Michael J Pishvaian, et al.The Journal of Infectious Diseases|June 1, 1995
High-dose pentoxifylline in patients with AIDS: inhibition of tumor necrosis factor production. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials GroupB J Dezube, M M Lederman, J G Spritzler, et al.Journal of Acquired Immune Deficiency Syndromes|July 1, 1993
Pentoxifylline decreases tumor necrosis factor expression and serum triglycerides in people with AIDS. NIAID AIDS Clinical Trials GroupB J Dezube, A B Pardee, B Chapman, et al.Pageof 8